ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,620,987 | -18.8% | 1,214,860 | 0.0% | 1.46% | -4.3% |
| Q2 2023 | $8,151,711 | -24.0% | 1,214,860 | 0.0% | 1.52% | -27.0% |
| Q1 2023 | $10,727,214 | +131.0% | 1,214,860 | +99.9% | 2.09% | +95.0% |
| Q4 2022 | $4,644,050 | -46.3% | 607,860 | -50.0% | 1.07% | -46.0% |
| Q3 2022 | $8,650,000 | -12.0% | 1,214,860 | 0.0% | 1.98% | -13.4% |
| Q2 2022 | $9,828,000 | -30.2% | 1,214,860 | +19.7% | 2.29% | -34.0% |
| Q1 2022 | $14,086,000 | -33.1% | 1,014,860 | +35.2% | 3.47% | -32.4% |
| Q4 2021 | $21,066,000 | +40.4% | 750,760 | +70.1% | 5.13% | +7.8% |
| Q3 2021 | $15,005,000 | +42.4% | 441,466 | +71.2% | 4.76% | +31.7% |
| Q2 2021 | $10,535,000 | +29.4% | 257,827 | +27.5% | 3.61% | +13.1% |
| Q1 2021 | $8,141,000 | +64.8% | 202,220 | +142.1% | 3.20% | +1.1% |
| Q4 2020 | $4,939,000 | – | 83,535 | – | 3.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |